Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;16(11):816-8.
doi: 10.1089/dia.2014.0261. Epub 2014 Sep 5.

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations

Yves Reznik  1 , Suiying Huang; OpT2mise Study Group
Collaborators, Affiliations

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations

Yves Reznik et al. Diabetes Technol Ther. 2014 Nov.
No abstract available

PubMed Disclaimer

References

    1. Brown JB, Nichols GA, Perry A: The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535–1540 - PubMed
    1. Grant RW, Cagliero E, Dubey AK, et al. : Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med 2004;21:150–155 - PubMed
    1. Rubino A, McQuay LJ, Gough SC, et al. : Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412–1418 - PubMed
    1. Nathan DM, Buse JB, Davidson MB, et al. : Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17–30 - PubMed
    1. Riddle MC, Rosenstock J, Gerich J, et al. : The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080–3086 - PubMed

MeSH terms

LinkOut - more resources